US science and technology group Danaher has agreed to pay $9.6 billion to buy Aldevron, a compatriot contract developer and manufacturer of biologics for the...
20.08.2019
- Private investor EQT VIII Fund has agreed to take a majority stake in Aldevron, a US-based biologics supplier. The transaction is expected to close by the end of 2019, subject to...
